Thiel and Novogratz to invest in biopharma firm

As 54.5 million new shares are being sold in Australia-based biopharma company Bionomics, officials involved announced that hedge fund legends Peter Thiel and Michael Novogratz are among . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.